The pharmacist and the management of arterial hypertension: The role of blood pressure monitoring and telemonitoring

Expert Review of Cardiovascular Therapy

Volumn 13, Issue 2, 2015, Pages 209-221

  Omboni, Stefano ^a   Sala, Elisa ^a  

^a ITALIAN INSTITUTE OF TELEMEDICINE   (Italy)

Author keywords

ambulatory blood pressure telemonitoring; blood pressure telemonitoring; home blood pressure telemonitoring; hypertension; pharmacy; telemedicine

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR MORTALITY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HOME MONITORING; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; LENGTH OF STAY; LIFESTYLE MODIFICATION; MEDICAL INFORMATICS; MEDICATION THERAPY MANAGEMENT; META ANALYSIS (TOPIC); PATIENT COUNSELING; PATIENT EDUCATION; PHARMACIST; PHARMACIST ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMINDER SYSTEM; REVIEW; SYSTOLIC BLOOD PRESSURE; TELEHEALTH; TELEMONITORING; TREATMENT REFUSAL; BLOOD PRESSURE; PHYSIOLOGY; PROCEDURES;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION; PHARMACISTS;

EID: 84921462936     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2015.1001368     Document Type: Review

References (48)

1. Lawes CM, Vander Hoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008;371:1513-18
2. Parati G, Stergiou GS, Asmar R, et al. ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens 2010;24:779-85
3. Parati G, Omboni S. Role of home blood pressure telemonitoring in hypertension management, an update. Blood Press Monit 2010;15:285-95
4. Purcell R, McInnes S, Halcomb EJ. Telemonitoring can assist in managing cardiovascular disease in primary care: a systematic review of systematic reviews. BMC Family Practice 2014;15:34
5. Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens 2013;31: 455-67.
6. Zullig LL, Melnyk SD, Goldstein K, et al. The role of home blood pressure telemonitoring in managing hypertensive populations. Curr Hypertens Rep 2013;15: 346-55
7. Omboni S, Guarda A. Impact of home blood pressure telemonitoring and blood pressure control: a meta-analysis of randomized controlled studies. Am J Hypertens 2011;24:989-98
8. Verberk WJ, Kessels AG, Thien T. Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis. Blood Press Monit 2011;16: 149-55
9. Pare G, Mogadem K, Pineau G, St-Hilaire C. Clinical effects of home telemonitoring in the context of diabetes, asthma, heart failure and hypertension: a systematic review. J Med Internet Res 2010;12:e21
10. AbuDagga A, Resnick HE, Alwan M. Impact of blood pressure telemonitoring on hypertension outcomes: a literature review. Telemed J E Health 2010;16:830-8
11. Uhlig K, Patel K, Ip S, et al. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med 2013;159:185-94
12. Proia KK, Thota AB, Njie GJ, et al. The community preventive services task force. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med 2014;47: 86-99
13. Carter BL, Bosworth HB, Green BB. The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy. J Clin Hypertens 2012;14:51-65
14. Nkansah N, Mostovetsky O, Yu C, et al. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev 2010;CD000336
15. Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother 1999;33: 1336-55
16. Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care 2010;48:923-33
17. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006;166:955-64
18. Higgins L, Brown M, Murphy JE, et al. Community pharmacy and pharmacist staff call center: assessment of medication safety and effectiveness. J Am Pharm Assoc 2011;51:82-9
19. Kjeldsen LJ, Bjerrum L, Dam P, et al. Safe and effective use of medicines for patients with type 2 diabetes-A randomized controlled trial of two interventions delivered by local pharmacies. Res Social Adm Pharm 2015;11(1):47-62
20. Ahmad A, Nijpels G, Dekker JM, et al. Effect of a pharmacist medication review in elderly patients discharged from the hospital. Arch Intern Med 2012;172:1346-7
21. Stewart K, George J, Mc Namara KP, et al. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial). J Clin Pharm Ther 2014;39: 527-34
22. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007;41:1770-81
23. Morgado MP, Morgado SR, Mendes LC, et al. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm 2011;68:241-53
24. Santschi V, Chiolero A, Colosimo AL, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc 2014;3:e000718
25. Erdem DG, Erdem E, Dilek M, et al. Accuracy of sphygmomanometers at pharmacies. Kidney Blood Press Res 2009;32:231-4
26. O'Brien E, Atkins N, Stergiou G, et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit 2010;15:23-38
27. Association for the Advancement of Medical Instrumentation. Non-invasive sphygmomanometers - Part 2: clinical validation of automated measurement type. ANSI/AAMI/ISO 81060-2:2013 Association for the Advancement of Medical Instrumentation; Arlington, Virginia: 2013
28. Ross KL, Bhasin S, Wilson MP, et al. Accuracy of drug store blood pressure monitors: an observational study. Blood Press Monit 2013;18:339-41
29. Gonzalvo J, Zillich A. Accuracy of automated community pharmacy-based blood pressure devices. J Am Pharm Assoc 2011;51:408-11
30. Karwalajtys T, Kaczorowski J, Hutchison B, et al. Blood pressure variability and prevalence of hypertension using automated readings from multiple visits to a pharmacy-based community-wide programme. J Human Hypertens 2009;23: 585-9
31. Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortolá A, Martínez-Martínez F. Comparison of the white-coat effect in community pharmacy versus the physician's office: the Palmera study. Blood Press Monit 2011;16:62-6
32. Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortolá Á, Martínez-Martínez F. Agreement between community pharmacy, physician's office, and home blood pressure measurement methods: the PALMERA Study. Am J Hypertens 2012;25:290-6
33. Sabater-Hernandez D, de la Sierra A, Sanchez-Villegas P, et al. MEPAFAR Study Workgroup. Magnitude of the white-coat effect in the community pharmacy setting: the MEPAFAR study. Am J Hypertens 2011;24:887-92
34. Sabater-Hernandez D, Sendra-Lillo J, Faus MJ, et al. Usefulness of blood pressure measurement by community pharmacists in the management of hypertension. J Manag Care Pharm 2012;18:453-6
35. Sabater-Hernandez D, Sanchez-Villegas P, Lacampa P, et al. Evaluation of the hypertensive state in treated patients: selection of appropriate blood pressure measurements per visit to the community pharmacy. Blood Press Monit 2011;16: 103-10
36. Sabater-Hernández D, de la Sierra A, Bellver-Monzo O, et al. Guía de actuacion para el farmaceutico comunitario en pacientes con hipertension arterial y riesgo cardiovascular. Documento de consenso (version resumida). Hipertension 2011;28: 169-81
37. Houle SK, Padwal R, Tsuyuki RT. The 2012-2013 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update. Can Pharm J 2013;146:146-50
38. Weber CA, Ernst ME, Sezate GS, et al. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med 2010;170:1634-9
39. Kerby TJ, Asche SE, Maciosek MV, et al. Adherence to blood pressure telemonitoring in a cluster-randomized clinical trial. J Clin Hypertens 2012;14:668-74
40. Green BB, Cook AJ, Ralston JD, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA 2008;299:2857-67
41. Green BB, Anderson ML, Ralston JD, et al. Blood pressure 1 year after completion of web-based pharmacist care. JAMA Intern Med 2013;173:1250-2
42. Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA 2013;310: 46-56.
43. Magid DJ, Ho PM, Olson KL, et al. A multimodal blood pressure control intervention in 3 healthcare systems. Am J Manag Care 2011;17:e96-103
44. Welch LK, Olson KL, Snow KE, et al. Systolic blood pressure control after participation in a hypertension intervention study. Am J Manag Care 2011;17:473-8
45. Wentzlaff DM, Carter BL, Ardery G, et al. Sustained blood pressure control following discontinuation of a pharmacist intervention. J Clin Hypertens 2011;13: 431-7
46. Carter BL, Doucette WR, Franciscus CL, et al. Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention. Pharmacotherapy 2010;30: 228-35
47. James K, Dolan E, O'Brien E. Making ambulatory blood pressure monitoring accessible in pharmacies. Blood Press Monit 2014;19:134-9
48. Omboni S, Caserini M. Telemonitoring of 24-h blood pressure in local pharmacies and blood pressure control in the community: results from the TEMPLAR project. J Hypertens 2014;32(e-Suppl 1):e13; asbtract